Milestone Scientific (NYSE:MLSS – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01), Yahoo Finance reports. The business had revenue of $1.85 million during the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%.
Milestone Scientific Stock Down 0.8 %
Shares of MLSS traded down $0.01 during trading on Friday, reaching $0.97. 62,905 shares of the company traded hands, compared to its average volume of 109,900. The stock has a market cap of $75.10 million, a PE ratio of -9.73 and a beta of 0.88. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.19. The stock has a 50-day simple moving average of $0.83 and a 200-day simple moving average of $0.73.
Wall Street Analysts Forecast Growth
Separately, StockNews.com started coverage on Milestone Scientific in a research note on Wednesday. They issued a “hold” rating on the stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
- Five stocks we like better than Milestone Scientific
- Best Aerospace Stocks Investing
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Manufacturing Stocks Investing
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.